Kefauver Case Study

The Kefauver–Harris Amendments signed during 1962 by President John F. Kennedy, addressed the concerns of both, the escalating cost of medication as well as increased governmental regulations for the Food and Drug Administration to control the pharmaceutical industry’s practices in reporting. As reported by Greene and Podolsky, Senator Kefauver considered, “The “captivity” of the prescription-drug consumer in the face of price gouging and dubious claims of efficacy under-scored the need for the state to ensure that innovative industries worked to the benefit of the average American” (“Reform, Regulation, and Pharmaceuticals” 1481). Even though Senator Kefauver initial intent was to investigate the increasing cost of medication, this amendment